Carbapenem Resistance and Mortality in Institutionalized Elderly With Urinary Infection

Journal of the American Medical Directors Association

Volumn 14, Issue 7, 2013, Pages 513-517

  Marinosci, Felice ^a   Zizzo, Alessandro ^a   Coppola, Anna ^a   Rodano, Leonardo ^a   Laudisio, Alice ^b   Antonelli Incalzi, Raffaele ^a,b  

^a Fondazione 'S Raffaele Cittadella della Carità'   (Italy)

^b UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

Carbapenem resistance; Elderly; Nursing home; Urinary tract infection

Indexed keywords

CARBAPENEM; CEPHALOSPORIN; COTRIMOXAZOLE; FOSFOMYCIN; PENICILLIN DERIVATIVE; QUINOLONE DERIVATIVE;

AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; COGNITION; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GERIATRIC DISORDER; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NURSING HOME; PREVALENCE; URINARY TRACT INFECTION; URINE CULTURE;

EID: 84879600723     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2013.02.016     Document Type: Article

References (40)

1. Stamm W.E., Norrby S.R. Urinary tract infections: disease panorama and challenges. JInfect Dis 2001, 183:S1-S4.
2. Hartstein A.I., Garber S.B., Ward T.T., et al. Nosocomial urinary tract infection: a prospective evaluation of 108 catheterized patients. Infect Control 1981, 2:380-386.
3. Richards M.J., Edwards J.R., Culver D.H., Gaynes R.P. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med 1999, 27:887-892.
4. Tambyah P.A., Maki D.G. Catheter-associated urinary tract infection is rarely symptomatic: a prospective study of 1497 catheterized patients. Arch Intern Med 2000, 160:678-682.
5. Pettersson E., Vernby A., Mölstad S., Lundborg C.S. Infections and antibiotic prescribing in Swedish nursing homes: a cross-sectional study. Scand J Infect Dis 2008, 40:393-398.
6. Sotto A., De Boever C.M., Fabbro-Peray P., et al. Risk factors for antibiotic-resistant Escherichia coli isolated from hospitalized patients with urinary tract infections: A prospective study. JClin Microbiol 2001, 39:438-444.
7. Brabazon E., Carton M., Dornikova G., Bedford D. Epidemiology and resistance patterns in urinary pathogens from long-term care facilities and GP populations. Ir Med J 2012, 105:177-180.
8. Parish A., Holliday K. Long term care acquired urinary tract infections' antibiotic resistance patterns and empiric therapy: A pilot study. Geriatr Nurs 2012, 33:473-478.
9. Pop-Vicas A., Mitchell S.L., Kandel R., et al. Multidrug-resistant gram-negative bacteria in a long-term care facility: Prevalence and risk factors. JAm Geriatr Soc 2008, 56:1276-1280.
10. Bonomo R.A. Multiple antibiotic-resistant bacteria in long term care facilities: An emerging problem in the practice of infectious diseases. Clin Infect Dis 2000, 31:1414-1422.
11. Hsueh P.R., Hoban D.J., Carmeli Y., et al. Consensus review of the epidemiology and appropriate antimicrobial therapy of complicated urinary tract infections in Asia-Pacific region. JInfect 2011, 63:114-123.
12. Schwaber M.J., Navon-Venezia S., Kaye K.S., et al. Clinical and economic impact of bacteremia with extended- spectrum-beta-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother 2006, 50:1257-1262.
13. Chant C., Smith O.M., Marshall J.C., Friedrich J.O. Relationship of catheter-associated urinary tract infection to mortality and length of stay in critically ill patients: A systematic review and meta-analysis of observational studies. Crit Care Med 2011, 39:1167-1173.
14. Fennell J., Vellinga A., Hanahoe B., et al. Increasing prevalence of ESBL production among Irish clinical Enterobacteriaceae from 2004 to 2008: An observational study. BMC Infect Dis 2012, 12:116.
15. Lambert M.L., Suetens C., Savey A., et al. Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: A cohort study. Lancet Infect Dis 2011, 11:30-38.
16. Urban C., Bradford P.A., Tuckman M., et al. Carbapenem-resistant Escherichia coli harboring Klebsiella pneumoniae carbapenemase beta-lactamases associated with long term care facilities. Clin Infect Dis 2008, 46:e127-e130.
17. Gupta N., Limbago B.M., Patel J.B., Kallen A.J. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis 2011, 53:60-67.
18. Warren J.W., Abrutyn E., Hebel J.R., et al. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis 1999, 29:745-758.
19. Hooton T.M., Bradley S.F., Cardenas D.D., et al. Infectious Diseases Society of America. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis 2010, 50:625-663.
20. Folstein M.F., Folstein S.E., McHugh P.R. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. JPsychiatr Res 1975, 12:189-198.
21. Katz S., Ford A.B., Moskowitz R.W., et al. Studies of illness in the aged. The index of ADL: A standardized measure of biological and psychosocial function. JAMA 1963, 185:914-919.
22. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. Anew method of classifying prognostic comorbidity in longitudinal studies: development and validation. JChronic Dis 1987, 40:373-383.
23. WHO Collaborating Centre for Drug Statistics Methodology. ATC/DDD Methodology: History. Oslo, Norway: World Health Organization, 1982.
24. World Health Organization. International Classification of Diseases. Available at: Accessed June 26,2012. http://www.who.int/classifications/icd/en/.
25. Peña C., Suarez C., Gozalo M., et al. Spanish Network for Research in Infectious Diseases REIPI. Prospective multicenter study of the impact of carbapenem resistance on mortality in Pseudomonas aeruginosa bloodstream infections. Antimicrob Agents Chemother 2012, 56:1265-1272.
26. Ben-David D., Kordevani R., Keller N., et al. Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections. Clin Microbiol Infect 2012, 18:54-60.
27. Patel G., Huprikar S., Factor S.H., et al. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 2008, 29:1099-1106.
28. Schwaber M.J., Klarfeld-Lidji S., Navon-Venezia S., et al. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother 2008, 52:1028-1033.
29. Lau S.H., Reddy S., Cheesbrough J., et al. Major uropathogenic Escherichia coli strain isolated in the northwest of England identified by multilocus sequence typing. JClin Microbiol 2008, 46:1076-1080.
30. Schlackow I., Stoesser N., Walker A.S., et al. Infections in Oxfordshire Research Database Team. Increasing incidence of Escherichia coli bacteraemia is driven by an increase in antibiotic-resistant isolates: Electronic database study in Oxfordshire 1999-2011. JAntimicrob Chemother 2012, 67:1514-1524.
31. de Kraker ME, Jarlier V, Monen JC, et al. The changing epidemiology of bacteraemias in Europe: Trends from the European Antimicrobial Resistance Surveillance System [published online ahead of print October 3, 2012]. Clin Microbiol Infect doi:10.1111/1469-0691.12028.
32. Wiener-Well Y., Rudensky B., Yinnon A.M., et al. Carriage rate of carbapenem-resistant Klebsiella pneumoniae in hospitalised patients during a national outbreak. JHosp Infect 2010, 74:344-349.
33. Gijón D., Curiao T., Baquero F., et al. Fecal carriage of carbapenemase-producing Enterobacteriaceae: A hidden reservoir in hospitalized and nonhospitalized patients. JClin Microbiol 2012, 50:1558-1563.
34. Lye D.C., Earnest A., Ling M.L., et al. The impact of multidrug resistance in healthcare-associated and nosocomial Gram-negative bacteraemia on mortality and length of stay: Cohort study. Clin Microbiol Infect 2012, 18:502-508.
35. Kwak Y.G., Choi S.H., Choo E.J., et al. Risk factors for the acquisition of carbapenem-resistant Klebsiella pneumoniae among hospitalized patients. Microb Drug Resist 2005, 11:165-169.
36. Falagas M.E., Rafailidis P.I., Kofteridis D., et al. Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: A matched case control study. JAntimicrob Chemother 2007, 60:1124-1130.
37. Hussein K., Sprecher H., Mashiach T., et al. Carbapenem resistance among Klebsiella pneumoniae isolates: Risk factors, molecular characteristics, and susceptibility patterns. Infect Control Hosp Epidemiol 2009, 30:666-671.
38. Ahmad M., Urban C., Mariano N., et al. Clinical characteristics and molecular epidemiology associated with imipenem-resistant Klebsiella pneumoniae. Clin Infect Dis 1999, 29:352-355.
39. Pakyz A.L., Oinonen M., Polk R.E. Relationship of carbapenem restriction in 22 university teaching hospitals to carbapenem use and carbapenem-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother 2009, 53:1983-1986.
40. Gould C.V., Umscheid C.A., Agarwal R.K., et al. Healthcare Infection Control Practices Advisory Committee. Guideline for prevention of catheter-associated urinary tract infections 2009. Infect Control Hosp Epidemiol 2010, 31:319-326.